🔥🐔 BizChicken 🐔🔥

Companies Similar to Vanda Pharmaceuticals Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

Rencofilstat

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing drug therapies for chronic liver diseases, particularly through the development of Rencofilstat, a cyclophilin inhibitor aimed at treating non-alcoholic steatohepatitis (NASH) and reducing liver fibrosis and tumors.

Tags: NASH, Rencofilstat, biopharmaceutical, cyclophilin inhibitor, drug therapy, liver disease

Symbol: HEPA

Recent Price: $0.43

Industry: Biotechnology

CEO: Mr. John Patrick Brancaccio CPA

Sector: Healthcare

Employees: 22

Address: 399 Thornall Street, Edison, NJ 08837

Phone: 732 902 4000

Leadership

  • John P. Brancaccio, Interim Chief Executive Officer, Interim Chief Financial Officer, and Chairman of the Board

Last updated: 2024-12-31

Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc. logo
Market Cap: Highest
Employees: Medium

ENHANZE drug delivery technology

Halozyme Therapeutics, Inc. is a biopharma technology platform company specializing in enabling subcutaneous delivery of biologics using its patented ENHANZE technology. The company operates in the United States and internationally, offering products such as Hylenex recombinant and developing treatments for various medical conditions including lymphomas and immunodeficiency disorders.

Tags: ENHANZE, biologics, biopharma, drug delivery, technology, therapeutics

Symbol: HALO

Recent Price: $47.99

Industry: Biotechnology

CEO: Dr. Helen I. Torley M.B. Ch. B., M.R.C.P.

Sector: Healthcare

Employees: 373

Address: 11388 Sorrento Valley Road, San Diego, CA 92121

Phone: 858 794 8889

Last updated: 2024-12-31

KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

KVD001, sebetralstat, KVD824, Factor XIIa

Kal Vista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company focused on discovering, developing, and commercializing small molecule protease inhibitors for diseases with unmet needs, including hereditary angioedema and diabetic macular edema.

Tags: Clinical Trials, Diabetic Macular Edema, Hereditary Angioedema, Pharmaceuticals, Protease Inhibitors

Symbol: KALV

Recent Price: $8.39

Industry: Biotechnology

CEO: Mr. Benjamin L. Palleiko

Sector: Healthcare

Employees: 150

Address: 55 Cambridge Parkway, Cambridge, MA 02142

Phone: 857 999 0075

Leadership

  • Albert Cha, Member of Board of Directors
  • William (Bill) Fairey, Member of Board of Directors
  • Benjamin L. Palleiko, Chief Executive Officer and Director
  • Brian J. G. Pereira, Member of Board of Directors
  • Nancy Stuart, Member of Board of Directors
  • Pat Treanor, Member of Board of Directors
  • Edward W. Unkart, Member of Board of Directors

Last updated: 2024-12-31

Oncternal Therapeutics, Inc.

Oncternal Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

zilovertamab, ONCT-216, ONCT-808, ONCT-534

Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in oncology therapies for cancers with significant unmet medical needs, featuring a pipeline that includes the monoclonal antibody zilovertamab and various other targeted treatments.

Tags: CAR-T, ROR1, antibody, biopharmaceutical, cancer therapy, clinical-stage, oncology

Symbol: ONCT

Recent Price: $0.53

Industry: Biotechnology

CEO: Dr. James B. Breitmeyer M.D., Ph.D.

Sector: Healthcare

Employees: 27

Address: 12230 El Camino Real, San Diego, CA 92130

Phone: 858 434 1113

Last updated: 2024-12-31

Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. logo
Market Cap: Low
Employees: Low

HETLIOZ, Fanapt

Vanda Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing and commercializing therapies for high unmet medical needs, including marketed products like HETLIOZ for sleep-wake disorders and Fanapt for schizophrenia, with ongoing development for other conditions.

Tags: Fanapt, HETLIOZ, biopharmaceutical, schizophrenia, sleep disorders, therapies

Symbol: VNDA

Recent Price: $4.78

Industry: Biotechnology

CEO: Dr. Mihael H. Polymeropoulos M.D.

Sector: Healthcare

Employees: 203

Address: 2200 Pennsylvania Avenue NW, Washington, DC 20037

Phone: 202 734 3400

Last updated: 2024-12-31

VistaGen Therapeutics, Inc.

VistaGen Therapeutics, Inc. logo
Market Cap: Low
Employees: Lowest

PH94B

Vista Gen Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing medicines for anxiety, depression, and other CNS disorders. Their CNS pipeline includes PH94B and PH10, rapid-onset neuroactive nasal sprays for anxiety and depression, respectively.

Tags: AV-101, CNS disorders, PH10, PH94B, anxiety treatment, biopharmaceutical, depression treatment

Symbol: VTGN

Recent Price: $2.81

Industry: Biotechnology

CEO: Mr. Shawn K. Singh J.D.

Sector: Healthcare

Employees: 41

Address: 343 Allerton Avenue, South San Francisco, CA 94080

Phone: 650 577 3600

Leadership

  • Ann Cunningham, MBA, Director
  • Joanne Curley, Ph.D., Director
  • Maggie FitzPatrick, Chair of the Board
  • Jerry Gin, Ph.D., MBA, Director
  • Mary L. Rotunno, J.D., Director
  • Jon S. Saxe, J.D., LL.M, Director
  • Shawn K. Singh, J.D., Chief Executive Officer and Director

Last updated: 2024-12-31

Zentalis Pharmaceuticals, Inc.

Zentalis Pharmaceuticals, Inc. logo
Market Cap: Low
Employees: Low

ZN-c3, ZN-c5

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics for treating various cancers. Its leading product candidates include ZN-c3 and ZN-c5, which are in various phases of clinical trials targeting specific cancer types.

Tags: biopharmaceutical, cancer treatment, clinical trials, small molecule therapeutics

Symbol: ZNTL

Recent Price: $2.92

Industry: Biotechnology

CEO: Dr. Kimberly Lynn Blackwell M.D.

Sector: Healthcare

Employees: 124

Address: 1359 Broadway, New York, NY 10018

Phone: 212 433 3791

Last updated: 2024-12-31

ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc. logo
Market Cap: High
Employees: Medium

NUPLAZID

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company committed to the development and commercialization of small molecule drugs to treat unmet medical needs in central nervous system disorders. Key products and developments include NUPLAZID for Parkinson's disease-related psychosis and a diverse pipeline addressing Alzheimer's disease, schizophrenia, Rett syndrome, and pain management.

Tags: Alzheimer's disease, Biopharmaceuticals, CNS disorders, Drug development, NUPLAZID, Pain management, Parkinson's disease, Rett syndrome, Schizophrenia

Symbol: ACAD

Recent Price: $16.69

Industry: Biotechnology

CEO: Ms. Catherine E. Owen Adams

Sector: Healthcare

Employees: 597

Address: 12830 El Camino Real, San Diego, CA 92130

Phone: 858 558 2871

Last updated: 2024-12-31

Eli Lilly and Company

Eli Lilly and Company logo
Market Cap: Highest
Employees: Highest

Pharmaceuticals

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide, specializing in treatments for diabetes, cancer, and other conditions.

Tags: Biotechnology, Cancer Treatment, Diabetes, Pharmaceuticals

Symbol: LLY

Recent Price: $773.84

Industry: Drug Manufacturers - General

CEO: Mr. David A. Ricks

Sector: Healthcare

Employees: 43000

Address: Lilly Corporate Center, Indianapolis, IN 46285

Phone: 317 276 2000

Last updated: 2024-12-31

Inhibikase Therapeutics, Inc.

Inhibikase Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

Ik T-148009

Inhibikase Therapeutics, Inc. is a clinical stage pharmaceutical company focused on developing therapeutics for Parkinson's Disease and related disorders. Their product pipeline includes treatments for neurological and cancer-related conditions.

Tags: Cancer Treatment, Neurological Disorders, Parkinson's Disease, Pharmaceutical, Therapeutics

Symbol: IKT

Recent Price: $3.24

Industry: Biotechnology

CEO: Dr. Milton H. Werner Ph.D.

Sector: Healthcare

Employees: 8

Address: 3350 Riverwood Parkway SE, Atlanta, GA 30339

Phone: 678 392 3419

Leadership

  • Milton H. Werner, Ph.D., President and CEO
  • C. Warren Olanow MD, FRCPC, FRCP (Hon.), Medical Consultant and CEO of Clintrex Research Corporation
  • Garth Lees-Rolfe, CPA, Chief Financial Officer
  • Dan Williams, Controller
  • Terence Kelly, Ph.D., Medicinal Chemistry Consultant
  • Surendra Singh, Ph.D., Chemistry and Manufacturing Controls
  • Merrill M. Kraines, Partner, McDermott, Will & Emery, Outside General Counsel
  • Roberto Bellini, Managing Partner at BSQUARED Capital
  • Dennis Berman, Serial Entrepreneur
  • David Canner, Ph.D., Partner at Soleus Capital
  • Roy Freeman, M.D., Professor of Neurology at the Harvard Medical School, Director of the Center for Autonomic and Peripheral Nerve Disorders, Beth Israel Deaconess Medical Center
  • Arvind Kush, Chief Financial Officer and Chief Business Officer of Candid Therapeutics
  • Amit Munshi, Chief Executive Officer of Orna Therapeutics

Last updated: 2024-12-31

Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated logo
Market Cap: High
Employees: Lowest

Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.

Tags: biopharmaceutical, commercial programs, disease treatment, medicine development, pharmaceutical technology

Symbol: LGND

Recent Price: $105.76

Industry: Biotechnology

CEO: Mr. Todd C. Davis Ph.D.

Sector: Healthcare

Employees: 58

Address: 5980 Horton Street, EmeryVille, CA 94608

Phone: 858 550 7500

Last updated: 2024-12-31

Lipocine Inc.

Lipocine Inc. logo
Market Cap: Lowest
Employees: Lowest

TLANDO

Lipocine Inc. is a clinical-stage biopharmaceutical company focused on developing pharmaceutical products for neuroendocrine and metabolic disorders using oral delivery solutions. Its lead product is TLANDO, an oral testosterone replacement therapy.

Tags: biopharmaceutical, metabolic disorders, neuroendocrine disorders, oral delivery, testosterone therapy

Symbol: LPCN

Recent Price: $4.58

Industry: Biotechnology

CEO: Dr. Mahesh V. Patel Ph.D.

Sector: Healthcare

Employees: 17

Address: 675 Arapeen Drive, Salt Lake City, UT 84108

Phone: 801 994 7383

Last updated: 2024-12-31

MEI Pharma, Inc.

MEI Pharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

Zandelisib

MEI Pharma, Inc. is a late-stage pharmaceutical company focused on developing and commercializing therapies for cancer treatment, including Zandelisib and Voruciclib.

Tags: Voruciclib, Zandelisib, cancer therapy, clinical trials, oncology, pharmaceutical

Symbol: MEIP

Recent Price: $2.45

Industry: Biotechnology

CEO: Mr. Justin J. File

Sector: Healthcare

Employees: 28

Address: 11455 El Camino Real, San Diego, CA 92130

Phone: 858 369 7100

Last updated: 2024-12-31

Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Medium

vonoprazan

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing treatments for gastrointestinal diseases, with significant advancements in the use of vonoprazan in clinical trials.

Tags: P-CAB, biopharmaceutical, clinical trials, gastrointestinal diseases, vonoprazan

Symbol: PHAT

Recent Price: $8.00

Industry: Biotechnology

CEO: Ms. Terrie J. Curran

Sector: Healthcare

Employees: 452

Address: 100 Campus Drive, Florham Park, NJ 07932

Phone: 877 742 8466

Last updated: 2024-12-31

Sagimet Biosciences Inc.

Sagimet Biosciences Inc. logo
Market Cap: Low
Employees: Lowest

Denifanstat

Sagimet Biosciences Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics called fatty acid synthase (FASN) inhibitors for diseases caused by dysfunctional lipid metabolism pathways. Its lead drug candidate, Denifanstat, targets nonalcoholic steatohepatitis and acne. The company is also working on FASN inhibitors for cancer treatment.

Tags: Denifanstat, FASN inhibitors, acne, biopharmaceutical, cancer, nonalcoholic steatohepatitis

Symbol: SGMT

Recent Price: $4.72

Industry: Biotechnology

CEO: Mr. David A. Happel

Sector: Healthcare

Employees: 8

Address: 155 Bovet Road, San Mateo, CA 94402

Phone: 650-561-8600

Leadership

  • George Kemble, PhD, Executive Chairman of the Board
  • David Happel, Chief Executive Officer
  • Anne Phillips, MD,
  • Beth Seidenberg, MD,
  • Elizabeth Grammer, Esq,
  • Jennifer Jarrett,
  • Merdad Parsey, MD, PhD,
  • Paul Hoelscher,
  • Tim Walbert,

Last updated: 2024-12-31

Vincerx Pharma, Inc.

Vincerx Pharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

VIP152

Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company focused on researching and developing therapies to address unmet medical needs for cancer treatment in the United States. Their lead product candidate, VIP152, is a cyclin-dependent kinase-9 inhibitor for advanced cancer.

Tags: biopharmaceutical, cancer treatment, clinical-stage, oncology, therapy development

Symbol: VINC

Recent Price: $0.33

Industry: Biotechnology

CEO: Dr. Ahmed M. Hamdy M.D.

Sector: Healthcare

Employees: 42

Address: 260 Sheridan Avenue, Palo Alto, CA 94306

Phone: 650 800 6676

Last updated: 2024-12-31

Viking Therapeutics, Inc.

Viking Therapeutics, Inc. logo
Market Cap: Highest
Employees: Lowest

VK2809

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapies for metabolic and endocrine disorders, with lead drug candidate VK2809 in Phase IIb trials for non-alcoholic steatohepatitis.

Tags: VK2809, biopharmaceutical, clinical-stage, endocrine disorders, metabolic disorders, therapies

Symbol: VKTX

Recent Price: $39.77

Industry: Biotechnology

CEO: Dr. Brian Lian Ph.D.

Sector: Healthcare

Employees: 30

Address: 9920 Pacific Heights Boulevard, San Diego, CA 92121

Phone: 858 704 4660

Leadership

  • Lawson Macartney, DVM, Ph.D., Chairman
  • Matthew W. Foehr, Chief Executive Officer
  • Kathy Rouan, Ph.D.,
  • Charles A. Rowland Jr.,
  • Matthew Singleton,
  • Brian Lian, Ph.D.,

Last updated: 2024-12-31

Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc. logo
Market Cap: Lowest
Employees: Low

VP-102, VP-103

Verrica Pharmaceuticals Inc. develops and commercializes treatments for skin diseases in the United States, including products for molluscum contagiosum and warts. The company collaborates with Torii Pharmaceutical Co., Ltd., and Lytix Biopharma AS for further development and commercialization efforts.

Tags: dermatology, molluscum contagiosum, oncology, pharmaceuticals, skin diseases, warts

Symbol: VRCA

Recent Price: $0.70

Industry: Biotechnology

CEO: Mr. Ted White

Sector: Healthcare

Employees: 100

Address: 44 West Gay Street, West Chester, PA 19380

Phone: 484 453 3300

Last updated: 2024-12-31

Biohaven Pharmaceutical Holding Company Ltd.

Biohaven Pharmaceutical Holding Company Ltd. logo
Market Cap: High
Employees: Low

NURTEC ODT (rimegepant)

Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops product candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States.

Tags: biopharmaceutical, migraine treatment, neurological diseases, neuropsychiatric disorders, rare disorders

Symbol: BHVN

Recent Price: $35.78

Industry: Biotechnology

CEO: Dr. Vladimir Coric M.D.

Sector: Healthcare

Employees: 239

Address: 215 Church Street, New Haven, CT 06510

Phone: 203 404 0410

Last updated: 2024-12-31

Enanta Pharmaceuticals, Inc.

Enanta Pharmaceuticals, Inc. logo
Market Cap: Low
Employees: Low

N/A

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases, with targets including respiratory syncytial virus, SARS-Co V-2, human metapneumovirus, and hepatitis B virus.

Tags: SARS-Co V-2, biotechnology, hepatitis B virus, liver diseases, pharmaceuticals, respiratory syncytial virus, small molecule drugs, viral infections

Symbol: ENTA

Recent Price: $5.85

Industry: Biotechnology

CEO: Dr. Jay R. Luly Ph.D.

Sector: Healthcare

Employees: 145

Address: 500 Arsenal Street, Watertown, MA 02472

Phone: 617 607 0800

Leadership

  • Jay R. Luly, Ph.D., President, Chief Executive Officer and Director
  • Tara L. Kieffer, Ph.D., Chief Product Strategy Officer
  • Matthew P. Kowalsky, J.D., Chief Legal Officer
  • Brendan Luu, Chief Business Officer
  • Paul J. Mellett, Chief Financial and Administrative Officer
  • Yat Sun Or, Ph.D., Chief Scientific Officer
  • Scott T. Rottinghaus, M.D., Chief Medical Officer
  • Bruce L.A. Carter, Ph.D., Chairman of the Board
  • Mark G. Foletta, Board Member
  • Yujiro S. Hata, Board Member
  • Kristine Peterson, Board Member
  • Lesley Russell, MBChB, MRCPb, Board Member
  • Terry Vance, Board Member

Last updated: 2024-12-31